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The NF-κB family of transcription factors plays a central role in the inducible expression
of inflammatory genes during the immune response, and the proper regulation of these
genes is a critical factor in the maintenance of immune homeostasis. The chromatin envi-
ronment at stimulus-responsive NF-κB sites is a major determinant in transcription factor
binding, and dynamic alteration of the chromatin state to facilitate transcription factor
binding is a key regulatory mechanism. NF-κB is in turn able to influence the chromatin
state through a variety of mechanisms, including the recruitment of chromatin modify-
ing co-activator complexes such as p300, the competitive eviction of negative chromatin
modifications, and the recruitment of components of the general transcriptional machin-
ery. Frequently, the selective interaction with these co-activators is dependent on specific
post-translational modification of NF-κB subunits. Finally, the mechanisms of inducible NF-
κB activity in different immune cell types seem to be largely conserved. The diversity of
cell-specific NF-κB-mediated transcriptional programs is established at the chromatin level
during cell differentiation by lineage-defining transcription factors. These factors generate
and maintain a cell-specific chromatin landscape that is accessible to NF-κB, thus restricting
the inducible transcriptional response to a cell-appropriate output.
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INTRODUCTION
Upon pathogen detection, the innate immune system must be able
to mount a robust and rapid response, but equally important is the
need to rein in the cytotoxic effects of the inflammatory response.
Therefore, modulation of pro-inflammatory gene expression is of
fundamental importance in the maintenance of immune home-
ostasis. Pro-inflammatory genes are maintained in a silent, yet
poised, state that can be rapidly induced in response to differ-
ent stimuli, and this characteristic pattern is achieved through the
action of two elements: the activation of inducible transcription
factors and the modulation of the chromatin environment at gene
regulatory elements.
Multiple signaling pathways are activated in response to
immune and inflammatory stimuli, resulting in the activation
of many different transcription factors. The transcription factors
induced upon stimulation must interact with cis-regulatory ele-
ments of target genes to facilitate recruitment of the general tran-
scriptional machinery. The chromatin state at these cis-elements
plays a critical role in modulating the activity of transcription fac-
tors, mainly by functioning as a steric barrier to DNA binding
and as a post-translational regulatory platform that influences the
recruitment of transcriptional cofactors. This review will focus
on the interplay of the archetypal inducible transcription factor
NF-κB with the chromatin environment, and discuss how the
chromatin presents a selective regulatory barrier to NF-κB activ-
ity and how NF-κB alters the chromatin environment to induce
transcription of inflammatory genes.
The NF-κB family of transcription factors is conserved through
metazoan organisms. These transcription factors are characterized
by a unique DNA-binding motif known as the Rel homology
domain (RHD). In mammals, there are five RHD containing
proteins: p65 (RelA), c-Rel, RelB, p100/p50, and p105/p52. Each
protein is capable of forming homodimers and heterodimers, with
15 dimer combinations possible (1). In unstimulated cells, NF-κB
is sequestered in the cytoplasm by the inhibitor of NF-κB fam-
ily (IκB) via their ankyrin repeat domains. Upon stimulation, the
IκB kinase (IKK) complex is activated and phosphorylates serine
residues on IκB molecules, targeting them for ubiquitination by
the SCF E3 ligase and subsequent degradation by the proteasome.
Degradation of IκB releases NF-κB, which translocates into the
nucleus to initiate a transcriptional response (2).
BASIC TRANSCRIPTIONAL MECHANISMS
Transcription can fundamentally be understood as the interaction
of cis- and trans-acting factors within the nucleus that orchestrate
the expression of a particular gene. The cis-acting elements are
defined as non-coding DNA elements located on the same chro-
mosome as the protein-coding locus. Two critical cis-elements
are the promoter and the enhancer. Trans-acting factors include
sequence-specific transcription factors (such as NF-κB and IRF),
chromatin modifying complexes (such as histone acetyltrans-
ferases and chromatin remodeling complexes), the mediator com-
plex, and finally general transcriptional factors (GTFs), including
RNA polymerase II (3–5).
Transcription initiates from the cis-regulatory element known
as the promoter, which can be divided into two portions, the core
promoter and the proximal promoter. The core promoter contains
regulatory elements that bind Pol II and the general transcriptional
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machinery, extending from −35 to +35 relative to the transcrip-
tional start site. The distal promoter extends ~300 bp upstream
from the core promoter and serves as the binding site for sequence-
specific transcription factors. It is thought that proximal promoter
binding transcription factors coordinate with distal enhancer-
binding transcription factors to recruit the mediator complex and
the general transcriptional machinery.
A number of conserved elements comprise the core promoter.
This includes, but is not limited to, the BRE (TFIIB recognition
element), TATA box, initiator, and downstream promoter ele-
ment (DPE). However, not all of these elements are absolutely
required for a promoter to be functional. In addition to these
discrete elements, vertebrate promoters are also distinguished by
their CpG dinucleotide content, with high CpG content promoters
commonly classified as CpG-island promoters (CGI) (6–8). How-
ever, all these regulatory elements function within the context of
chromatin.
Eukaryotic DNA is highly condensed, a necessary strategy for
the compaction of large genomes into a relatively small nuclear
volume. This is achieved by the wrapping of DNA around his-
tone proteins. The resultant DNA:histone complex is referred
to as the nucleosome, which is the core repeating unit of the
chromatin. The degree of compaction of chromatin fibers plays
an important role in accessibility of DNA-binding proteins for
their cognate binding sites. Furthermore, elongating polymerases
encounter nucleosomal barriers during their progression through
the locus. Thus,chromatin presents additional layers of complexity
to the mechanism of transcription (9).
There are four major histone proteins, H2A, H2b, H3, and
H4. Two copies of each protein form the histone octamer, and
147 bp of DNA wraps around the octamer to form the nucleo-
some. The interaction of DNA and the octamer is highly stable.
High-resolution crystal structures have shown that there are over
100 points of contact between the octamer and DNA, and that
the DNA is stabilized by arginine residues of the octamer directly
contacting the minor groove of DNA (10).
HISTONES AND CHROMATIN MODIFICATION DOMAINS AT
REGULATORY ELEMENTS
The tails of histone proteins are subject to a broad range of post-
translational modifications that influence all aspects of chromatin
biology. Histone modification is thought to have two major pur-
poses: (1) the alteration of net charge of the tail, which has an
effect on tail-DNA interactions and inter-histone interactions;
(2) the generation of recognition sites for activating or repressive
factors (9).
Lysine acetylation and methylation have been the most well-
studied histone modifications that regulate transcription. Addi-
tion of acetyl residues is accomplished by histone acetyltransferase
complexes (HATs), and removal of these marks is catalyzed by
histone deacetylases (HDACs). HATs, such as the p300/CBP com-
plex, are generally non-specific and are able to target multiple
lysine residues on various histone proteins. Lysine acetylation is
largely associated with active transcription. Acetylation of H4K16
has been shown to have a significant impact on the compaction of
nucleosomal arrays in vitro, and is a general mark of euchromatin
in vivo. The specialized domain that recognizes acetylated lysines
is known as the bromodomain. Proteins that have bromodomains
include HATs and chromatin remodeling complexes such as RSC
and SWI/SNF (11, 12).
Lysine methylation can act as an activating or repressive
mark, depending on the specific residue modified. For example,
trimethylation of H3K4 is strongly associated with active tran-
scription, and is found at active promoters, while methylation
of H3K9 and H3K27 is associated with transcriptional repres-
sion. In contrast to acetyltransferases, methyltransferase have very
restricted substrate specificities, in keeping with the more special-
ized and context-dependent roles that methylated lysines have.
Furthermore, methylated lysine residues have relatively restricted
distributions across gene loci; for example, H3K4me3 is enriched
at promoters of active genes, while H3K4me1 has been more
recently recognized as an enhancer-specific mark, and finally
H3K36me3 and H3K79me are found within gene bodies (3, 11).
SETTING THE STAGE: DEVELOPMENTAL ESTABLISHMENT OF AN
NF-κB-RESPONSIVE GENE PROGRAM
NF-κB dimers are broadly distributed, especially in cells of the
immune system, and are activated in response to a variety of
cell-specific receptor stimuli (e.g., TCR in T-cells, pattern recog-
nition receptors in myeloid cells). In response to these stimuli
however, NF-κB is able to induce the expression of a diverse
range of genes tailored to a specific cellular response. Such cell-
type specific response is established during development and is
broadly speaking, the result of lineage-defining transcription fac-
tors binding to enhancer elements at an early developmental stage.
In macrophages for example, the major lineage-determining tran-
scription factors PU.1 and C/EBP and AP-1 families bind cognate
enhancer elements and establish an active chromatin state. This
renders the enhancer and promoter elements accessible to addi-
tional factors, resulting in a cell-specific array of binding sites in
genes that have been epigenetically primed for binding to acti-
vated NF-κB (13, 14). The establishment of an inducible epigenetic
landscape is not the only mechanism by which NF-κB binding is
modulated. Many loci require the synergistic activity of multiple
signal-dependent transcription factors, as well as further mod-
ulation of the chromatin structure at enhancers and promoter
elements.
REGULATION BEFORE THE SIGNAL: CHROMATIN AS A DETERMINANT
FOR NF-κB BINDING ACTIVITY
The concerted activity of lineage-defining transcription factors
and inducible transcription factors are required for the proper reg-
ulation of inflammatory genes expression. Along those lines, the
synergistic activity of multiple inducible transcription factors is
frequently necessary to overcome the inhibitory chromatin state at
inflammatory genes. A classic example of transcription factor syn-
ergism is the induction of the human interferon-β (IFNB) gene in
response to viral infection. Stimulus-dependent expression of this
gene requires the cooperative binding of three transcription fac-
tors: NF-κB, IRF3/IRF7, and ATF-2/c-JUN. NF-κB initially binds
to the conserved PRDII element in the promoter. This in turn
facilitates the recruitment of IRF and ATF-2/c-Jun. Once properly
assembled at the promoter, these transcription factors serve as a
platform for the sequential recruitment of the PCAF chromatin
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modifying complex, the p300/CBP acetyltransferase, and subse-
quently the SWI/SNF chromatin remodeling complexes. SWI/SNF
remodels the downstream nucleosome that encompasses the TATA
box, thus allowing TBP binding and subsequent pre-initiation
complex assembly (15–17). The regulation of the IFNβ enhanceo-
some is an important illustration of transcriptional regulation
through the combinatorial control of multiple transcriptional fac-
tors, and how only the concerted effort of these factors can resolve
the presence of a chromatin barrier.
Studies on the regulation of expression of the cytokine gene
Il12b have shown that a non-permissive chromatin configuration
functions as regulatory barrier that must be inducibly resolved for
proper gene expression. Early studies on Il12b expression focused
on identifying critical transcription factor binding sites by sys-
tematic mutation of promoter–reporter constructs. These studies
showed that NF-κB, specifically the c-Rel subunit, in conjunction
with C/EBP, AP-1, and NFAT transcription factors, are required
for Il12b activation (18–21). Nucleosomal mapping of endoge-
nous Il12b promoter revealed that the critical transcription factor
binding sites were occupied by a positioned nucleosome extend-
ing from −30 to −175 upstream of the transcriptional initiation
site, and that this nucleosome was selectively remodeled upon
LPS stimulation. Furthermore, this promoter remodeling event
was dependent on de novo protein synthesis, but was independent
of c-Rel binding, as evidenced by promoter remodeling occur-
ring in c-Rel deficient cells that lacked the ability to express Il12b
(22–24). Thus, in contrast to the enhanceosome, which required
NF-κB in a synergistic complex to recruit chromatin remodeling
complexes, Il12b operates under a slightly different mode of reg-
ulation in which remodeling is required prior to DNA binding.
Moreover, since NF-κB genes are induced with variable kinetics,
there would appear to be multiple chromatin-based regulatory
strategies governing the binding of NF-κB.
To this end, Saccani and colleagues made the important obser-
vation that although NF-κB RelA subunits entered the nucleus
rapidly upon stimulation, they only bound to a subset of genes
initially (25). Other genes were bound at later time points, suggest-
ing that their binding sites were inaccessible, consistent with the
observations at the Il12b promoter. Inspection of the chromatin
modifications at early versus late bound genes showed a consis-
tent pattern: early recruiting genes had higher levels of histone
acetylation while late bound genes had low basal acetylation lev-
els that increased upon stimulation (25). From these data, a model
emerged in which NF-κB binding was inhibited at certain promot-
ers during the early phase of stimulation by inaccessible chromatin
structure, and NF-κB could only bind these late gene promoters
after critical chromatin remodeling events had occurred.
Implicit in this model is the idea that NF-κB itself lacks the
ability to bind a chromatinized template and requires the binding
of additional factors capable of recruiting chromatin remodeling
complexes. This hypothesis is supported by structural studies of
NF-κB, which showed its precise binding to a naked DNA tem-
plate (26–28). It has been reported that NF-κB p50-homodimers
can indeed bind nucleosomal κB sites in vitro, albeit at a reduced
efficiency than the naked template (29, 30). Furthermore, the
positioning of the binding site within the nucleosome strongly
influenced the binding affinity of p50, with binding sites near the
edge of the nucleosome being highly favored. The in vitro nucleo-
some binding was also at least partially dependent on remodeling
complex activity or partial disassembly of the histone octamer
(31). It remains to be seen whether this nucleosome binding activ-
ity is specific to p50-homodimers and its specific cognate site, or
whether it is a common feature shared by a broad variety of NF-
κB dimers and binding sites. Interestingly, p50 dimer complexes
have been observed in the nucleus of unstimulated cells, which are
displaced by activating dimers (RelA or c-Rel species) in stimu-
lated cells presumably after chromatin remodeling has occurred
(32, 33). Given that p50 lacks a trans-activation domain, and has
been shown to associate with deacetylase complexes, the latent p50
binding to a more compact chromatin template may be part of a
regulatory strategy keeping genes silent under resting conditions
by maintaining a repressive chromatin environment (32).
Although it is clear that differential chromatin states influence
the NF-κB response, the mechanisms that contribute to inducible
chromatin remodeling remained unclear. To test whether specific
chromatin remodeling complexes were required for expression
of NF-κB dependent genes, Ramirez-Carrozzi and colleagues tar-
geted the SWI/SNF chromatin remodeling complex by retroviral
knockdown of its ATPase subunits, Brg and Brm (34). This protein
complex was a likely candidate for chromatin remodeling as it had
been shown to be strongly associated with gene activation in var-
ious contexts. In the targeted cells, the chromatin remodeling of
Il12b was strongly inhibited, concurrent with a loss in expression
of Il12b. The knockdown, however, had no effect on the inducible
expression of another gene, the rapidly expressed chemokine,
Cxcl2. Further comparison of the expression patterns of these two
genes revealed that (1) Cxcl2 was strongly induced upon 30 min
of LPS treatment while Il12b was most strongly induced only after
2 h of treatment and (2) expression of Cxcl2 was not inhibited by
protein synthesis inhibitors, indicating that it is a primary response
gene. Based on such criteria including induction kinetics, protein
synthesis requirement, and SWI/SNF dependence, inducible genes
could be partitioned into three classes: early primary, late pri-
mary,and secondary. The early primary response class was induced
rapidly and did not require either Brg1/Brm or new protein syn-
thesis and included genes such as Cxcl2, Tnf, and Ptgs2. However,
a subset of primary response genes (which included Ccl5, Saa3,
and Ifnb1) did require Brg1/Brm for activation and were induced
with delayed kinetics relative to remodeling-independent primary
response genes. Finally, secondary response class (which included
Il12b, Nos2, and Il6) required both Brg1/Brm and new protein syn-
thesis. ChIP analysis of Brg showed that the remodeling complex
was associated in an inducible fashion at remodeling-dependent
genes. Furthermore, nuclease sensitivity analysis at representa-
tive genes from each class showed a pattern consistent with their
dependence on Brg1/Brm. Namely, inducible promoter accessi-
bility was seen at late primary and secondary genes, and this
sensitivity was lost during knockdown of Brg1/Brm. In contrast,
early primary genes had much more accessible promoters and this
accessibility was unchanged by Brg1/Brm knockdown (34, 35).
This classification of inflammatory genes was further expanded
by the discovery that many remodeling-independent genes were
distinguished by the presence of a CpG island (CGIs) (35,36). CGIs
are prevalent in the promoters of ~70% of protein-coding gene
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promoters, including the promoters of ubiquitously expressed
housekeeping genes (37). The presence of CpG-island promoters
is highly correlated with an accessible chromatin configuration,
namely high levels of H3K4me3 marks, as well as pre-association
of Pol II in the basal state. The contribution CGIs to this favor-
able chromatin state is thought to emerge from multiple possible
mechanisms. First, the recruitment of chromatin modifying com-
plexes that deposit H3K4m3 marks and display specificity for CGIs
via CXXC domain containing proteins (38, 39). Secondly, CGI
sequences may be inherently unfavorable to the formation of sta-
ble, repressive nucleosome formation at these promoters (35, 40).
Finally, many transcription factors, such as Sp1, have binding affin-
ity for GC-rich sequences, and may contribute to the maintenance
of an open chromatin configuration of CGI promoters. In con-
trast, non-CpG-island genes were largely remodeling dependent,
and many such genes have been shown to be dependent on the IRF
transcription factors, which are competent for recruiting SWI/SNF
complexes.
These studies have generated a regulatory framework that inte-
grates the basal chromatin state with the kinetics of transcriptional
induction and selective requirement for chromatin remodeling.
Within this model, the kinetics of a particular gene’s expression
correlated with the basal chromatin state and the synthesis and
induction of transcription factors (such as IRF) capable of pro-
moting the remodeling of nucleosomal barriers to NF-κB dimer
recruitment and transcriptional activation. NF-κB dimers may still
be involved in recruitment of remodeling complexes but are most
likely to do so in cooperation with other transcription factors
(Figure 1).
Subsequent to binding, NF-κB plays a major, yet heteroge-
neous role, at the chromatin level. The many different interactions
between NF-κB and its various transcriptional cofactors have not
been extensively defined, and the molecular order of many of these
various interactions remain unclear. Nevertheless, it is accepted
that NF-κB regulates the expression of its target genes through
FIGURE 1 | Chromatin state at different promoter classes dictates the
kinetics of the NF-kB response. (A) CpG-island promoters (red dashed
lines) are characterized by high levels of histone H3K4me3 and more highly
accessible chromatin. This allows for rapid transcriptional induction by
NF-kB, independent of the need for any SWI/SNF-dependent nucleosome
remodeling. (B) Low-CpG promoters contain inactive and inaccessible
chromatin signatures in the basal state, which forms a barrier to NF-kB
binding and transcriptional activation. SWI/SNF complexes must be
recruited to these genes by additional factors such as IRF proteins in order
to facilitate chromatin remodeling. Upon chromatin remodeling, NF-kB can
bind and induce transcription.
a broad range of chromatin-mediated mechanisms. These roles
can be generalized into two broadly defined activities: recruit-
ment of positive cofactors/marks and the removal of negative
regulators/marks, as discussed below.
NF-κB IN THE NUCLEUS: A VARIETY OF ROLES AND A
VARIETY OF PARTNERS
RECRUITMENT OF CO-ACTIVATORS
NF-κB is capable of interacting with many different transcrip-
tional cofactors via its trans-activation domain, including chro-
matin modifying complexes and general transcription factors (41).
The purpose of these chromatin modifications is to serve as a
recruitment platform for additional activators, such as remodeling
complexes, enabling recruitment of the transcriptional machinery
to the promoter, followed by initiation of transcription. Although
many of these cofactors are essential for the expression of NF-
κB-induced genes, the mechanisms of how NF-κB can selectively
regulate or recruit them remains unclear.
One of the most well-characterized cofactors of NF-κB, specif-
ically the RelA subunit, is the p300/CBP histone acetyltransferase
complex. The interaction between these factors is interesting
in that it requires additional modification of RelA in order to
occur. Post-translational modifications of RelA have been shown
to play an important role in modulating the activity of NF-κB.
Although the mechanistic importance of many of these modi-
fications remains unclear, studies of specific residues have shown
that they may regulate the recruitment of transcriptional cofactors
such as histone acetyltransferases (HATs) or histone deacetylases
(HDACs). The p300/CBP complex is an important example of
a chromatin modifying complex that directly interacts with NF-
κB. Strikingly this interaction is regulated at the post-translational
level, being dependent on the specific phosphorylation of the RelA
protein.
The Ser276 residue of RelA can be phosphorylated, has been
shown to be targeted by the catalytic subunit of protein kinase A
(PKA), mitogen- and stress-activated protein kinase-1 (MSK1),
and Pim1 kinase (42–45). The importance of this phosphory-
lated serine was shown to be threefold: it moderately enhanced
DNA-binding activity of RelA; it caused a conformational shift
that allowed CBP/p300 binding in place of the latent interaction
of RelA with HDAC complexes; RelA deficient cells reconstituted
with S276A mutants were severely impaired in NF-κB dependent
gene expression (32, 45–48) (Figure 2). Most convincingly, the
absolute necessity of this phosphorylation event was demonstrated
by the generation of a knock-in mouse containing an alanine sub-
stitution at RelA S276 residue. Mice homozygous for S276A point
mutants were embryonic lethal between E11 and E16 and exhibited
severe developmental defects, most notably in eye development,
and embryonic fibroblasts showed a defect in the activation of
selective subsets of pro-inflammatory genes (47).
The interplay between p300/CBP and RelA illustrates critical
aspects of NF-κB biology. In order for NF-κB to fully function, it
must be activated by canonical NF-κB signaling, and then modi-
fied by a distinct signaling pathway. p300/CBP has also been shown
to acetylate RelA itself, notably on lysine 310. As with phosphory-
lation of Ser276, differential modification of Lys310 plays a major
role in dictating RelA cofactor specificity. Acetylation of the residue























































































FIGURE 2 | Chromatin state at different promoter classes dictates the
kinetics of the NF-kB response. (A) Release of NF-kB dimers through
appropriate stimulation is linked to phosphorylation of p65 at serine 276 in the
cytoplasm by PKAc or in the nucleus by MSK1/2. Phosphorylated p65
preferentially interacts with CBP/p300 co-activator complexes, displacing its
latent binding to HDAC complexes. The specific interaction of p65 and p300
results in the acetylation of p65 itself and of surrounding histones, and
subsequent transcriptional induction. (B)The acetylation of p65 on K310
promotes the recruitment of the positive elongation factors Brd4 and P-TEFb,
which can phosphorylate the polymerase C-terminus. p65 can also recruit
GCN5 acetyltransferase complexes, leading to promoter acetylation,
Brd4-P-TEFb recruitment, and polymerase elongation.
promotes an interaction with the histone acetyltransferase Tip60
and the transcriptional elongation factors PTEF-B (49–51). Con-
versely, methylation of Lys310 by the SET6 proteins facilitates an
interaction with the histone methyltransferase GLP/G9a, leading
to downregulation of transcription. The selective modulation of
these two residues highlights the functional diversity of NF-κB
in the control of the inflammatory response. Many other post-
translational modifications have been shown to occur on RelA,
with a corresponding enhancement or attenuation of transcription
of selective inflammatory genes (52, 53).
DE-REPRESSION: REMOVAL OF REPRESSIVE MARKS AND COMPLEXES
In addition to the inducible recruitment of activating marks,
another regulatory mechanism is to maintain a basal repres-
sive state at gene promoters. These repressive marks are subse-
quently removed upon stimulation. This phenomenon can occur
at the level of basal chromatin marks, or the binding of repres-
sive complexes. For example, some inducible gene promoters
have high levels of the H3K9 dimethyl modification, a repressive
mark associated with transcriptional silencing. Upon stimulation,
this mark is removed by the Aof1 histone demethylase, which is
recruited by initially bound c-Rel dimers (54, 55). Similarly, sub-
sets of inflammatory gene promoters are marked by the repressive
trimethyl H3K27 deposited by the Ezh2 methyltransferase, and
the inducible removal of this mark by the Jmjd3 demethylase
is required for their expression (56). The dynamic regulation of
this mark has proved to be of interest, due to the development
of a Jmjd3-specific pharmacological inhibitor that can attenuate
inducible pro-inflammatory gene expression (57).
The stimulus-dependent eviction of basally bound co-repressor
complexes at promoters is another chromatin-based strategy for
maintaining tight regulation on the expression of NF-κB depen-
dent genes. Nuclear receptor corepressor (NCoR) and the closely
related protein silencing mediator of retinoid and thyroid recep-
tors (SMRT) are multiprotein co-repressor complexes containing
histone deacetylases (HDACs), specifically HDAC3. These HDACs
function to keep H3K9/14 acetylation levels low in the resting
cell. Upon stimulation, this repressive state is relieved, allowing
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for the accumulation of activating marks and recruitment of the
transcriptional machinery. Similarly, NCoR/SMRT complexes are
also displaced, promoting NF-κB binding and recruitment of co-
activator complexes. It should be noted that both NCoR and
SMRT complexes function in non-redundant fashion, and are
recruited to regulatory elements by different sequence-specific
transcription factors: JUN homodimers and p50 dimers in the
case of NCoR, and the ETS-related protein, translocation–ETS–
leukemia (TEL) in the case of SMRT (36, 58, 59). In addition to
HDAC-dependent removal of activating marks, NCoR complexes
can maintain a silent state via the deposition of the repressive
H3K20me3 mark. Subsequently upon stimulation, these marks
are removed by the NF-κB dependent recruitment of histone
demethylase (60).
Because these repressive complexes restrain the expression of
inflammatory gene program in the basal state, one would pre-
dict that their targeted disruption would lead to hyperacetylation
and therefore enhanced expression of immune genes. Surprisingly
however this is not the case. Knockout of NCoR in macrophages
led to an anti-inflammatory phenotype, contrary to the expec-
tation that removal of a basal repressor would lead to the hyper-
responsiveness of pro-inflammatory genes. Although NF-κB bind-
ing activity appeared to be unaffected in these cells, the lack of the
basal repressive complex compromised the stimulus-dependent
deposition of H3K4me2, a mark associated with productive tran-
scription. The mechanism contributing to this phenotype was
attributed to the de-repression of metabolic pathways that sub-
sequently inhibit chromatin modifying complexes required for
induction of pro-inflammatory genes (61). Along similar lines,
HDAC3-deficient macrophages were defective in their ability to
activate a broad range of pro-inflammatory genes. Although the
knockout did result in hyperacetylation across immune genes,
there was a specific defect in the expression of IFNβ, which com-
promised overall STAT protein signaling and the secondary gene
response to TLR4 stimulation (62).
NF-κB-MEDIATED REGULATION OF Pol II ELONGATION
After polymerase recruitment to the promoter, sequential mod-
ifications of Pol II are required for productive transcription to
occur. The initial stage of transcriptional elongation requires local
unwinding of the promoter DNA. Characteristic of this stage is
the phosphorylation of serine 5 of the C-terminal heptad repeat
by the Cdk7 subunit of TFIIH, or the CDK8 subunit of the media-
tor complex. Ser5 phosphorylation serves as a platform to recruit
RNA capping enzymes to the nascent transcript (63, 64). A second
pause occurs ~40–50 bp downstream of the transcription initi-
ation site, and de-repression of this block requires the kinase
activity of P-TEFb. This final de-repression commits the poly-
merase to the elongation phase of transcription (65, 66). During an
inflammatory response, there is evidence for stimulus-dependent
unpausing being the major rate-limiting step in the expression of
rapidly induced genes (36, 67, 68). Along with the p300/CBP com-
plex, NF-κB has been shown to recruit GCN5 acetyltransferase
complexes, which primarily modify H4K5/K8/K12 lysines. These
residues have been shown to be deposited in response to NF-κB
binding. The accumulation of acetylated H4 in stimulated cells
allows binding of the bromodomain-containing protein BRD4,
which then plays a positive role in transcription by recruiting the
elongation factor P-TEFb (Figure 2) (36).
The signal-dependent elongation by Pol II is most prevalent at
rapidly induced CGI containing promoters, where the permissive
chromatin structure allows for a pre-assembled polymerase com-
plex to exist in the basal state. At these genes, the major regulatory
checkpoint is therefore the licensing of the polymerase to enter
a productive elongation phase, as opposed to the recruitment of
polymerase itself. Signal-dependent elongation is a well-conserved
regulatory mechanism, having been well-documented at the heat-
shock genes, and more recently at rapidly induced immune genes
in Drosophila (69, 70). The inhibition of BRD4 by highly selective
chemical compounds, however, revealed that such an inhibition
can selectively inhibit low-CpG containing genes (71). Although
BRD4 activity is essential for a broad class of NF-κB depen-
dent genes, the selective effect of the I-BET chemical antagonists
implies multiple mechanisms of BRD4 recruitment. Indeed, there
is evidence that acetylated NF-κB can directly recruit BRD4 (72).
CHROMATIN DYNAMICS AT ENHANCER REGIONS: A
MECHANISM FOR IMMUNOLOGICAL MEMORY AND
VARIABILITY?
Chromatin dynamics at promoters play a central role in how
inducible genes are regulated, but advances in genome-wide stud-
ies have shed new light on how enhancer regions can also play
a dynamic regulatory role. Because enhancer elements can be
located great distances from the transcriptional start sites (ranging
from a few kilobases to over a megabase), identification of bona
fide enhancers has been a significant challenge, and the mecha-
nisms of enhancer-mediated regulation of transcription remain
somewhat unclear. As discussed above, enhancers are important
in establishing the transcriptional competence of a locus follow-
ing the binding of lineage-specifying factors. A highly multiplexed
ChIP-seq study by Garber et al. in dendritic cells further developed
this model, differentiating enhancer-binding transcription factors
into three major regulatory classes: stably bound pioneer factors
C/EBP and PU.1, which presumably bind to inaccessible chro-
matin early in lineage commitment; “primer” factors, such as Jun
and AP-1, which are stably bound subsequent to pioneer factor
binding and presumably contribute to local chromatin modifi-
cation and remodeling; and finally the inducible factors, chiefly
NF-κB and STAT proteins (73). Concurrent with inducible tran-
scription factor binding, enhancer chromatin modifications are
also dynamic. Active enhancer regions in a broad variety of cell
types are distinguished by high levels of H3K4 monomethylation,
and a number of ChIP-seq studies have utilized this specific mark
to discover novel enhancers at a genome-wide level (74, 75).
The H3K27 acetyl mark has recently been demonstrated
as another important enhancer-associated modification (76).
Genome-wide analyses of this mark in macrophages has enabled
functional categorization of enhancer elements into constitutive,
poised, latent, and repressed classes based on the dynamics of
the two histone modifications and PU.1 binding. Constitutively
active enhancers are marked by PU.1 binding and high levels of
both H3K4m1 and H3K27ac that remain stable upon stimulation.
Poised enhancers only contain PU.1 and H3Km1, and H3K27 is
dynamically acetylated upon stimulation. Latent enhancers are
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devoid of these marks, which are deposited upon stimulation.
These enhancers govern the expression of late-phase genes, and
are established in a stimulus-specific manner. Specifically, activa-
tion via TNF and IL1β, potent activators of the NF-κB signaling
pathway, results in latent enhancers that are bound by the lin-
eage definer PU.1 and NF-κB. By contrast, interferon stimulation
results in the appearance of a latent enhancer repertoire enriched
for PU.1 and STAT/IRF binding sites. In this manner, cells that
have been exposed to a specific stimulus retain a short-term
epigenetic memory of that stimulus, facilitating a more rapid
and efficient transcriptional response upon subsequent stimula-
tion (77). On the other hand, repressive chromatin modifications
can be deposited at regulatory elements upon an initial stimu-
lus, thereby attenuating responses to a secondary stimulus, and
causing the cell to become tolerized against the stimulus. At the
level of chromatin, it has been shown that promoters of tolerizable
genes become hypoacetylated and adopt an inaccessible chromatin
structure and are subsequently hyporesponsive (78).
Given that enhancers play such an important modulatory role
in the inducible gene program, there has been considerable inter-
est in how genetic variation of regulatory elements can influence
gene expression. Heinz and colleagues recently showed that strain-
specific genetic variations at enhancers affected PU.1 and CEB/P
binding in macrophages. Loss or gain of these lineage-determining
factors was concomitant with alterations of H3Km1 and H3K27ac
levels, as well as the expression levels of nearby genes. Impor-
tantly, the variability in lineage-factor binding sites resulted in a
loss of NF-κB binding at enhancers, much more so than variation
of κB sites themselves (79). The strong correlation between loss of
lineage-factor binding, loss of chromatin modification, and loss
of NF-κB, support the role of NF-κB as a multifunctional switch
that can only bind to sites marked and poised by lineage-defining
factors.
FUTURE DIRECTIONS AND ADVANCES
In the 25 years since its discovery, NF-κB has become one of the
most heavily studied transcription factors. This is of course not
without cause, as it is well-appreciated that a number of disease
states, particularly inflammatory disease states, are at some level
due to dysregulated NF-κB signaling. This review has attempted to
summarize the broad range of chromatin-regulated mechanisms
that govern the specificity of NF-κB-mediated transcription, the
variety of ways NF-κB itself can influence chromatin structure, and
a survey of how epigenetic programs initiated in response to NF-κB
are established and propagated. A recurring theme in the study of
NF-κB is that this transcription factor rarely acts alone. Lineage-
determining transcription factors set the stage at the chromatin
level, thereby dictating the response NF-κB will induce. Further-
more, a number of chromatin changes must take place at NF-κB
dependent genes in order for proper gene induction to occur. In
this sense, NF-κB can be thought of as the final regulatory switch.
At rapidly induced genes, the switch controls late events such as the
licensing of a pre-assembled polymerase into a productive elon-
gation phase. In late-expressed genes, chromatin remodeling must
occur, polymerase must be recruited and transition into an elon-
gation phase takes place. This regulatory scheme largely focuses
on events at the promoter, and indeed only fairly recently have the
mechanisms of enhancer regulation been appreciated. However,
a number of outstanding questions remain to be answered. Post-
translational modification of NF-κB has long been appreciated
as an important regulatory mechanism, dictating cofactor speci-
ficity for active dimers, but the physiological necessity of many of
these modifications remains unclear outside of in vitro settings. In
many of these cases, the identity of modification-dependent inter-
action partners is unknown, and the spatiotemporal regulation
of the majority of modifications remains unclear. Furthermore,
the relative contributions of the multiple regulatory mechanisms
remain unclear. For example, the p300/CBP bound by NF-κB plays
a role in enhancing transcription of inducible genes (as in the
case of the IFNβ enhanceosome), but its direct acetylation of
NF-κB also plays a critical and perhaps more diverse regulatory
role. It is possible that NF-κB cofactor requirements are dictated
by cooperative transcription factor binding at specific regulatory
elements. As with the case of the RelA Ser276 residue, genera-
tion of genetic models targeted at specific residues would be of
tremendous value.
Genome-wide studies of the chromatin state during a patho-
genic response have strengthened the understanding of the various
regulatory mechanisms involved in establishing a competent tran-
scriptional response. Although our understanding of the dynamics
of NF-κB and its relationship with lineage-defining factors has
deepened, it should be noted that there are numerous transcrip-
tion factors and chromatin modifying complexes whose roles and
relationship with NF-κB remain to be further characterized. Inte-
grative and multiplexed studies have given us a snapshot of the
different hierarchies of transcription factor binding (73), and
similar studies examining the panoply of chromatin modifica-
tions will likely prove fruitful as well. By systematically targeting
different chromatin modifiers, either chemically or genetically, a
deeper understanding of the regulatory logic governing the NF-κB
transcriptional response can be developed.
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